365 related articles for article (PubMed ID: 8019250)
1. Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease.
Macgregor JE; Campbell MK; Mann EM; Swanson KY
BMJ; 1994 May; 308(6941):1407-11. PubMed ID: 8019250
[TBL] [Abstract][Full Text] [Related]
2. Frequency of cervical smear abnormalities within 3 years of normal cytology.
Sawaya GF; Kerlikowske K; Lee NC; Gildengorin G; Washington AE
Obstet Gynecol; 2000 Aug; 96(2):219-23. PubMed ID: 10908766
[TBL] [Abstract][Full Text] [Related]
3. Incidence of abnormal cervical and vaginal cytology among women over age 65 years living with human immunodeficiency virus.
Stewart KA; Allen SM; Chesnokova AE; Syed F; Levison JE
Am J Obstet Gynecol; 2020 May; 222(5):486.e1-486.e10. PubMed ID: 31678094
[TBL] [Abstract][Full Text] [Related]
4. The case for stopping cervical screening at age 50.
Cruickshank ME; Angus V; Kelly M; McPhee S; Kitchener HC
Br J Obstet Gynaecol; 1997 May; 104(5):586-9. PubMed ID: 9166202
[TBL] [Abstract][Full Text] [Related]
5. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
Sherman ME; Lorincz AT; Scott DR; Wacholder S; Castle PE; Glass AG; Mielzynska-Lohnas I; Rush BB; Schiffman M
J Natl Cancer Inst; 2003 Jan; 95(1):46-52. PubMed ID: 12509400
[TBL] [Abstract][Full Text] [Related]
6. Cervical intraepithelial neoplasia grade III (CIN III) and invasive cervical carcinoma: the yawning gap revisited and the treatment of risk.
Herbert A; Smith JA
Cytopathology; 1999 Jun; 10(3):161-70. PubMed ID: 10390064
[TBL] [Abstract][Full Text] [Related]
7. Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.
Ogilvie GS; van Niekerk D; Krajden M; Smith LW; Cook D; Gondara L; Ceballos K; Quinlan D; Lee M; Martin RE; Gentile L; Peacock S; Stuart GCE; Franco EL; Coldman AJ
JAMA; 2018 Jul; 320(1):43-52. PubMed ID: 29971397
[TBL] [Abstract][Full Text] [Related]
8. Relative risk of high grade squamous intraepithelial lesion associated with prior abnormal Pap smears.
Collins LC; Niloff J; Burke L; Abu-Jawdeh G; Wang H
J Reprod Med; 2001 Feb; 46(2):105-9. PubMed ID: 11255808
[TBL] [Abstract][Full Text] [Related]
9. Rationale for stopping cervical screening in women over 50.
Van Wijngaarden WJ; Duncan ID
BMJ; 1993 Apr; 306(6883):967-71. PubMed ID: 8490472
[TBL] [Abstract][Full Text] [Related]
10. High-grade squamous intraepithelial lesion in women aged <30 years has a prevalence pattern resembling low-grade squamous intraepithelial lesion.
Vale DB; Westin MC; Zeferino LC
Cancer Cytopathol; 2013 Oct; 121(10):576-81. PubMed ID: 23765869
[TBL] [Abstract][Full Text] [Related]
11. Incidence of cervical intraepithelial neoplasia grade III, and cancer of the cervix uteri following a negative Pap-smear in an opportunistic screening.
Gram IT; Macaluso M; Stalsberg H
Acta Obstet Gynecol Scand; 1998 Feb; 77(2):228-32. PubMed ID: 9512333
[TBL] [Abstract][Full Text] [Related]
12. Screening for cervical intraepithelial neoplasia in Dundee and Angus 1962-81 and its relation with invasive cervical cancer.
Duguid HL; Duncan ID; Currie J
Lancet; 1985 Nov; 2(8463):1053-6. PubMed ID: 2865526
[TBL] [Abstract][Full Text] [Related]
13. Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era?
Subramaniam A; Fauci JM; Schneider KE; Whitworth JM; Erickson BK; Kim K; Huh WK
J Low Genit Tract Dis; 2011 Apr; 15(2):110-3. PubMed ID: 21263352
[TBL] [Abstract][Full Text] [Related]
14. Benefit and burden in the Dutch cytology-based vs high-risk human papillomavirus-based cervical cancer screening program.
Loopik DL; Koenjer LM; Siebers AG; Melchers WJG; Bekkers RLM
Am J Obstet Gynecol; 2021 Feb; 224(2):200.e1-200.e9. PubMed ID: 32800820
[TBL] [Abstract][Full Text] [Related]
15. Risk of cervical cancer after completed post-treatment follow-up of cervical intraepithelial neoplasia: population based cohort study.
Rebolj M; Helmerhorst T; Habbema D; Looman C; Boer R; van Rosmalen J; van Ballegooijen M
BMJ; 2012 Oct; 345():e6855. PubMed ID: 23117059
[TBL] [Abstract][Full Text] [Related]
16. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
Safaeian M; Wright TC; Stoler MH; Ranger-Moore J; Rehm S; Aslam S; Fang Q; Volkir P; Ridder R
Am J Obstet Gynecol; 2021 Sep; 225(3):278.e1-278.e16. PubMed ID: 33852886
[TBL] [Abstract][Full Text] [Related]
17. Four and a half year follow up of women with dyskaryotic cervical smears.
Fletcher A; Metaxas N; Grubb C; Chamberlain J
BMJ; 1990 Sep; 301(6753):641-4. PubMed ID: 2224218
[TBL] [Abstract][Full Text] [Related]
18. Prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tract.
Troisi R; Hatch EE; Palmer JR; Titus L; Robboy SJ; Strohsnitter WC; Herbst AL; Adam E; Hyer M; Hoover RN
Am J Obstet Gynecol; 2016 Sep; 215(3):322.e1-8. PubMed ID: 26979629
[TBL] [Abstract][Full Text] [Related]
19. Management of women with mild and moderate cervical dyskaryosis.
Flannelly G; Anderson D; Kitchener HC; Mann EM; Campbell M; Fisher P; Walker F; Templeton AA
BMJ; 1994 May; 308(6941):1399-403. PubMed ID: 8019248
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with an increased risk of prevalent and incident grade III cervical intraepithelial neoplasia and invasive cervical cancer among women with Papanicolaou tests classified as grades I or II cervical intraepithelial neoplasia.
Petry KU; Böhmer G; Iftner T; Davies P; Brummer O; Kühnle H
Am J Obstet Gynecol; 2002 Jan; 186(1):28-34. PubMed ID: 11810080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
